HOP Tenon

Paris 75970

1 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Idiopathic Pulmonary Fibrosis, Lung Cancer, Non-squamous, Non-small Cell, Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Type 1 Interferonopathies

Studies at this site

• Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies — Running, not enrolling
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis — Completed
• Real World Data on Gi(l)Otrif® Dose Adjustment — Completed